Robert Weiss, M.D.

Robert H. Weiss, M.D.


Internal Medicine



Internal Medicine


  • Chief of Nephrology, Sacramento VA Medical Center
  • Professor
To see if Robert H. Weiss is accepting new patients, or for assistance finding a UC Davis doctor, please call 800-2-UCDAVIS (800-282-3284).

Lawrence J. Ellison Ambulatory Care Center

4860 Y St., Suite 0200
Sacramento, CA 95817
Driving Directions

Primary Phone:

Additional Phone Numbers

Phone: 800-4-UCDAVIS (800-482-3284)

Clinical Interests

Robert H. Weiss' clinical interests include the diagnosis and treatment of all renal diseases and electrolyte problems. His research interests concern the cyclins and cyclin inhibitors, cancer growth control (kidney and breast cancer), metabolomics and proteomics, and polycystic kidney disease.



Center/Program Affiliation

UC Davis Comprehensive Cancer Center


M.D., UC Irvine College of Medicine, Irvine, California, 1984

B.A., UC Santa Cruz, Santa Cruz, California, 1976

M.S., UCLA, Los Angeles, California, 1980


California-Pacific Medical Center, San Francisco, California, 1985-1987


University of California, San Francisco, San Francisco, California, 1991

Board Certifications

American Board of Internal Medicine, 1987

American Board of Internal Medicine, Nephrology, 1996

Professional Memberships

American Association for the Advancement of Science

American College of Physicians

American Society of Nephrology

Select Recent Publications

Chen H, Li C, Huang j, Cung T, Seiss K, Beamon J, Carrington MF, Porter LC, Burke PS, Yang Y, Ryan BJ, Kiu R, Weiss RH, Preyra F, Cress WD, Brass AL, Rosenberg ES, Walker BD, Yu XG, Lichterfeld M. CD4 T cells from elite controllers resist HIV-1 infection by selective upregulation of p21 cip-1/waf-1. Journal of Clinical Investigation. 2011 Apr 1;1214:1549-60.

Kim K, Taylor SL, Ganti S, Guo L, Osier M, Weiss RH. Urine metabolomic analysis identifies potential biomarkers and pathogenic pathways in kidney cancer, Omics., 2011 May;155:293-303.

Tayor SL, Ganti S, Bukanov NO, Chapman A, Fiehn O, Osier M, Kim K, Weiss RH. A metabolomics approach using juvenile cystic mice to identify urinary biomarkers and altered pathways in polycystic kidney disease. American Journal of Physiology: Renal Physiology. 2010 298:909-922, with Editorial Forum

Weiss, RH. Invited editorial (Weiss: Editor-in-Chief): Why another cancer journal? Cancers, 1(1):1-2, 2009

Perroud, B., Ishimaru, T., Borowsky, A.D., Weiss, RH. Grade-dependent proteomic characterization of kidney cancer, Molecular and Cellular Proteomics, May; 8(5):971-85, 2009

Kim, K.M., Aronov, P.A, Zakharkin, S.O., Anderson, D., Perroud, B., Weiss, RH., Urine metabolomic analysis for kidney cancer detection and biomarker discovery, Molecular and Cellular Proteomics, Mar; 8(3):558-70, 2009

Liu , J.-Y. Park, S.-H., Morisseau , C., Hwang, S. H., Hammock, B., Weiss, RH., Sorafenib Has she Inhibitory Activity Which Contributes to Its Effect Profile in vivo, Molecular Cancer Therapeutics, 2009 Aug; 8(8):2193-203, 2009

Park SH, Wang X, Liu R, Lam KS, Weiss RH. High throughput screening of a small molecule one-bead-one-compound combinatorial library to identify attenuators of p21 as chemotherapy sensitizers, Cancer Biology Therapy 2008 Dec 26;712.